ALKBH3 inhibitor (HOIST)

N/A

Report date: 2025/06/11 10:48:56
NME

Base Information

Drug NameALKBH3 inhibitor (HOIST)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionAlkB Homolog 3, Alpha-Ketoglutarate Dependent Dioxygenase inhibitors
TargetsAlkB Homolog 3, Alpha-Ketoglutarate Dependent Dioxygenase
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHOIST Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHOIST Co Ltd
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A